Search results
Former Auburn commit set to return to the Plains this weekend
Auburn Wire via Yahoo Sports· 18 hours agoThe recruitment of four-star defensive lineman Antonio Coleman can be described as a “mixed bag.”...
Accused killer who posted videos of fatal attack on Snapchat set for Monday trial
Gannett via AOL· 1 hour agoTimothy Kendrick, 35, is accused of fatally beating and stabbing 30-year-old Drew Mendelbaum to...
Elite 2026 ATH Derrek Cooper commits to Georgia
WSB Radio· 2 hours agoWhen elite 2026 athlete Derrek Cooper visited UGA back in April, he said that Athens was starting to feel like home. The South Florida athlete decided to...
LSU baseball commit Konnor Griffin named the 2023-24 Gatorade National Baseball Player of the Year
High School Sports via Yahoo Sports· 15 hours agoKonnor Griffin has been named the 2023-24 Gatorade National Baseball Player of the Year. It is yet...
5-star Ohio State commit planning visit to Oregon Ducks this summer
Ducks Wire via Yahoo Sports· 8 hours agoWhen looking at the future, there are few players better than 5-star wide receiver Chris Henry Jr.,...
Schnabel Says ECB Can’t Pre-Commit Amid Uncertain Price Outlook
Bloomberg· 3 hours agoThe European Central Bank is facing high uncertainty about the consumer-price outlook and needs to...
Waterloo taxi company concerned for industry's reputation as police warn of new scam
CBC via Yahoo News· 1 hour agoThe vice-president of Waterloo Taxi says he's concerned an elaborate new scam will harm the...
Former Spartan Defensive Lineman stays committed to Miami
Sports Illustrated· 41 minutes agoFormer Michigan State defensive lineman Simeon Barrow is expected to stick at the University of...
Four-star OL Rowan Byrne commits to Clemson
Rivals via Yahoo Sports· 17 hours ago-star Rowan Byrne could not wait any longer to announce his commitment. The New Rochelle (N.Y.) Iona Prep offensive lineman took an official visit to...
AbbVie's Tight Grip on Humira Market Raises Concerns About Biosimilars
US News & World Report· 1 hour agoHumira, which lists for almost $7,000 a month, is the first top-selling drug to compete with a slew of biosimilars, which are close but not exact copies of branded biologic medicines. Biosimilars ...